Clinical Trials

NCT03095781 | COMPLETED | PHASE1
47 participants

Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-22
Start Date:
2017-07-07
Completion:
2021-06-10
Conditions
  • Colorectal Adenocarcinoma
  • Metastatic Pancreatic Adenocarcinoma
  • Recurrent Colorectal Carcinoma
  • Recurrent Pancreatic Carcinoma
  • Stage III Colorectal Cancer
  • Stage III Pancreatic Cancer
  • Stage IIIA Colorectal Cancer
  • Stage IIIB Colorectal Cancer
  • Stage IV Colorectal Cancer
  • Stage IV Pancreatic Cancer
  • Stage IVA Colorectal Cancer
  • Stage IVA Pancreatic Cancer
  • Stage IVB Colorectal Cancer
  • Stage IVB Pancreatic Cancer
  • Unresectable Pancreatic Carcinoma
Interventions
  • DRUG
  • BIOLOGICAL
NCT03008408 | ACTIVE_NOT_RECRUITING | PHASE2
90 participants

A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-22
Start Date:
2017-08-18
Completion:
2028-08-31
Conditions
  • Recurrent Endometrial Carcinoma
  • Recurrent Endometrial Endometrioid Adenocarcinoma
  • Refractory Endometrial Carcinoma
  • Refractory Endometrial Endometrioid Adenocarcinoma
  • Stage III Uterine Corpus Cancer AJCC v8
  • Stage IIIA Uterine Corpus Cancer AJCC v8
  • Stage IIIB Uterine Corpus Cancer AJCC v8
  • Stage IIIC Uterine Corpus Cancer AJCC v8
  • Stage IIIC1 Uterine Corpus Cancer AJCC v8
  • Stage IIIC2 Uterine Corpus Cancer AJCC v8
  • Stage IV Uterine Corpus Cancer AJCC v8
  • Stage IVA Uterine Corpus Cancer AJCC v8
  • Stage IVB Uterine Corpus Cancer AJCC v8
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page